SCHEMBL24324246

SCHEMBL24324246

CC(C)(C)OC(=O)CCCC(=O)NCCCn1c(=O)c2cc(F)ccc2n2c(=S)[nH]nc12

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29446381 0.91 PLK1 (1.00) PLK1
SCHEMBL24324069 0.91 PLK1 (1.00) PLK1
SCHEMBL29446445 0.89 PLK1 (0.88) PLK1
SCHEMBL26852119 0.87 PLK1 (1.00) PLK1
SCHEMBL29446355 0.87 PLK1 (1.00) PLK1
SCHEMBL24324356 0.87 PLK1 (1.00) PLK1
SCHEMBL24324427 0.87 PLK1 (1.00) PLK1
SCHEMBL29446434 0.87 PLK1 (1.00) PLK1
SCHEMBL29446453 0.85 PLK1 (1.00) PLK1
SCHEMBL29446370 0.85 PLK1 (1.00) PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022067100-A2 PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-03-31 WO disclosed